{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:21:04Z","timestamp":1783387264887,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1598-0","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T07:04:13Z","timestamp":1562051053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Deep coma in a child treated with propranolol for infantile hemangioma"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-3765","authenticated-orcid":false,"given":"Ilirjana","family":"Bakalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Kola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lluka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermela","family":"Celaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durim","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inva","family":"Gjeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashenka","family":"Sallabanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea","family":"Klironomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"1598_CR1","unstructured":"Metry DW. Infantile hemangiomas: Management. UpTodate. Last updated may 16, 2018."},{"issue":"4","key":"1598_CR2","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","volume":"136","author":"H Darrow","year":"2015","unstructured":"Darrow H, Greene AK, Mancini AJ, Nooper AJ. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):e1060\u2013104.","journal-title":"Pediatrics"},{"issue":"4","key":"1598_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1542\/peds.2015-2482","volume":"136","author":"H Darrow","year":"2015","unstructured":"Darrow H, Greene AK, Mancini AJ, Nooper AJ. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):786\u201391.","journal-title":"Pediatrics"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C Leaute-Labreze","year":"2017","unstructured":"Leaute-Labreze C, Harper JI, Hoeger PH. Infantile hemangioma. Lancet. 2017;390:85.","journal-title":"Lancet"},{"issue":"1","key":"1598_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pde.12022","volume":"30","author":"K Martin","year":"2013","unstructured":"Martin K, Bleib F, Chamlin S, Chiu YE, Frieden I, Frommelt PC, et al. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. Pediatr Dermatol. 2013;30(1):155\u20139.","journal-title":"Pediatr Dermatol"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/s41598-018-22787-8","volume":"8","author":"Y Ji","year":"2018","unstructured":"Ji Y, Chen S, Wang Q, Xiang B, Xu Z, Zhong L, et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Sci Rep. 2018;8:4264.","journal-title":"Sci Rep"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/850193","volume":"2013","author":"Andreas Fette","year":"2013","unstructured":"Fette A. Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy. Sci World J. 2013;2013:850193.","journal-title":"The Scientific World Journal"},{"key":"1598_CR8","unstructured":"Treating hemangiomas with propranolol. Available at: \n                    https:\/\/www.gosh.nhs.uk\/medical-information-0\/medicines-information\/treating-haemangiomas-propranolol\n                    \n                   Last updated: June 2014."},{"key":"1598_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13052-017-0421-5","volume":"43","author":"A Tosoni","year":"2017","unstructured":"Tosoni A, Cutrone M, Carbonare MD, Pettenazzo A, Perilongo G, Sartori S. Cardiac arrest in a toddler treated with propranolol for infantile hemangioma: a case report. Ital J Pediatr. 2017;43:103.","journal-title":"Ital J Pediatr"},{"key":"1598_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0190-9622(97)70183-X","volume":"37","author":"IJ Frieden","year":"1997","unstructured":"Frieden IJ, Eichenfiled LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines\/Outcomes Comittess. J Am Acad Dermatol. 1997;37:631.","journal-title":"J Am Acad Dermatol"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/archderm.1997.03890480119022","volume":"133","author":"IJ Frieden","year":"1997","unstructured":"Frieden IJ. Which hemangiomas to treat- and how? Arch Dermatol. 1997;133:1593.","journal-title":"Arch Dermatol"},{"key":"1598_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C Leaute-Labreze","year":"2015","unstructured":"Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier j GL, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735.","journal-title":"N Engl J Med"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","volume":"26","author":"LP Lawly","year":"2009","unstructured":"Lawly LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610.","journal-title":"Pediatr Dermatol"},{"key":"1598_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","volume":"65","author":"M De Graaf","year":"2011","unstructured":"De Graaf M, Breur JM, Raphael MF, Vos M, Breugem CC, Pasmans SG. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol. 2011;65:320.","journal-title":"J Am Acad Dermatol"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41598-017-01321-2","volume":"7","author":"Y Ji","year":"2017","unstructured":"Ji Y, Chen S, Xiang B, Yang Y, Qiu L. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study. Sci Rep. 2017;7:1503.","journal-title":"Sci Rep"},{"key":"1598_CR16","unstructured":"Propranolol, oral tablet. Available at: \n                    https:\/\/www.healthline.com\/health\/propranolol-oral-tablet\n                    \n                   Last updated: Jan 17, 2018."},{"key":"1598_CR17","unstructured":"Propranolol for haemangiomas of infancy. British Association of Dermatologists. Available at: \n                    http:\/\/www.bad.org.uk\/shared\/get-file.ashx?id=177&itemtype=document\n                    \n                  ."},{"issue":"5","key":"1598_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/09546634.2012.755249","volume":"25","author":"D Jian","year":"2014","unstructured":"Jian D, Chen X, Babajee K, Su J, Hu X, Li J. Adverse effects of propranolol treatment for infantile hemangiomas in China. J Dermatol Treat. 2014;25(5):388\u201390.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"1598_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Sl C, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for of infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128\u201340.","journal-title":"Pediatrics"},{"issue":"5","key":"1598_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jaad.2011.10.036","volume":"66","author":"GP Prashanth","year":"2012","unstructured":"Prashanth GP. How \u201cunsafe\u201d is propranolol when used in the treatment of infantile hemangioma? JAAD. 2012;66(5):854\u20135.","journal-title":"JAAD"},{"issue":"7","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","volume":"146","author":"KE Holland","year":"2010","unstructured":"Holland KE, Frieden IJ, Frommel PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol. 2010;146(7):775\u20138.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1598_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00431-010-1324-2","volume":"170","author":"C Schiestl","year":"2011","unstructured":"Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kueber I, Michels R, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170(4):493\u2013501.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"1598_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1525-1470.2009.01081.x","volume":"27","author":"E Bonifazi","year":"2010","unstructured":"Bonifazi E, Acquafredda A, Milano A, Montagna O, Laforgia N. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol. 2010;27(2):195\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"1598_CR24","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1651-2227.2010.01990.x","volume":"99","author":"G Fusilli","year":"2010","unstructured":"Fusilli G, Merico G, Gurrado R, Rosa T, Acquafredda A, Cavallo L. Propranolol for infantile hemangioma and neuroglycopenic seizures. Acta Paediatr. 2010;99(12):1756.","journal-title":"Acta Paediatr"},{"issue":"4","key":"1598_CR25","doi-asserted-by":"publisher","first-page":"e20160353","DOI":"10.1542\/peds.2016-0353","volume":"138","author":"C Leaute-Labreze","year":"2016","unstructured":"Leaute-Labreze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbe G, et al. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. 2016;138(4):e20160353.","journal-title":"Pediatrics"},{"issue":"4","key":"1598_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2015.13969","volume":"315","author":"S Prey","year":"2016","unstructured":"Prey S, Voisard JJ, Delarue A, Lebbe G, Ta\u00efeb A, Leaute-Labreze C, et al. Safety of Propranolol Therapy for Severe Infantile Hemangioma. JAMA. 2016;315(4):413\u20135.","journal-title":"JAMA."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1598-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T23:57:21Z","timestamp":1593561441000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1598-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For publishing the case reports we obtained a written consent from the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}